Loading reports catalog...
Loading reports catalog...
Access deep-dive research across global industry sectors to empower your strategic decision-making with data-driven insights.
Explore our comprehensive collection of healthcare market research reports, offering in-depth insights into the rapidly evolving global healthcare ecosystem. Our detailed analysis covers various segments, providing crucial medical device market analysis and identifying emerging trends across pharmaceuticals, biotechnology, and healthcare IT. As part of our specialized offerings, we provide granular data on niche sectors like the sterilization equipment market, ensuring industry leaders have the actionable intelligence needed for strategic planning and competitive benchmarking. Our reports deliver precise market sizing, growth forecasts, and competitive landscape assessments to guide your business decisions in the dynamic healthcare industry.
Showing 126 Results
The U.S. neurovascular devices market was estimated at USD 2.9 billion and is projected to grow at a CAGR of 5.5% from USD 3.01 billion in 2026 to USD 4.9 billion in 2035. The market is undergoing significant expansion, fueled by the growing incidence of neurological conditions and the escalating impact of cerebrovascular illnesses nationwide. Additionally, enhancing investments in stroke care facilities and neurointerventional laboratories, coupled with growing awareness of early detection and treatment, is fostering market expansion.
The U.S. nasal cannula market was estimated at USD 2.5 billion in 2025 and is expected to grow at a CAGR of 5.3% from USD 2.7 billion in 2026 to USD 4.2 billion in 2035. The market is experiencing consistent expansion, fueled by the rising incidence of respiratory conditions like chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and acute respiratory infections. Additionally, the increasing rate of hospital admissions caused by respiratory issues, particularly in emergency and intensive care environments, is elevating the need for nasal cannulas as a key oxygen delivery method. For instance, in situations involving pneumonia, complications from COVID-19, and recovery after surgery, nasal cannulas are commonly utilised in hospitals for providing low to moderate levels of oxygen.
The U.S. midline catheter market was evaluated at USD 1,168.43 million in 2025 and is projected to expand at a CAGR of 5.3% from USD 1,220.66 million in 2026 to USD 1,946.06 million in 2035. The strong market growth is propelled by the escalating demand for safer and extended-duration intravenous access, a rise in hospital admissions, and a heightened preference for less invasive vascular access devices. Moreover, the increasing elderly population in the U.S. is leading to elevated hospitalization rates and a heightened need for vascular access solutions that minimize complications such as phlebitis and bloodstream infections related to catheters.
The U.S. low sterilisation equipment market size was estimated at USD 974.22 million in 2025 and is expected to expand at a CAGR of 10.5% from USD 1,067.25 million in 2026 to USD 2,621.14 million in 2035. The robust market growth is mainly fueled by the growing need for sterilizing heat- and moisture-sensitive medical instruments, increasing numbers of surgical procedures, and strict infection control standards in healthcare settings. Furthermore, the growing prevalence of healthcare-associated infections (HAIs), the increasing use of minimally invasive techniques, and a heightened focus on adhering to sterilization standards set by regulatory authorities are driving market expansion.
The global stool management systems market was evaluated at USD 1,771.66 million in 2025 and is projected to grow with a CAGR of 5.1% from USD 1,842.52 million in 2026 to USD 2,882.57 million in 2035. The strong market expansion is driven by the rising frequency of fecal incontinence, heightened occurrence of critically ill patients needing extended intensive care, and increasing focus on infection prevention in medical environments. Moreover, the increasing focus on decreasing hospital-acquired infections (HAIs), especially in intensive care units (ICUs), is driving the implementation of closed-loop stool management systems that aid in minimising skin breakdown, preventing cross-contamination, and enhancing patient hygiene.
The continuous glucose monitoring devices market was valued at USD 13.5 billion in 2025, and is expected to grow at a CAGR of 15.1% from USD 15.4 billion in 2026 to USD 54.9 billion in 2035. The strong market expansion is mainly fueled by the escalating global incidence of diabetes, heightened awareness regarding the significance of continuous glucose monitoring, and the increasing use of advanced diabetes management technologies. Additionally, technological innovations like factory-tuned sensors, wearable and minimally invasive CGM devices, smartphone integration, cloud-based data sharing, and AI-driven glucose analysis are improving user convenience and clinical results.
Stay informed with updates on related market reports and key industry topics.